Vistin Pharma ASA (OB: VISTN)
Health Care · Pharmaceuticals · NO
Nkr18.10
-0.55% today · -20.6% 1Y
Vistin Pharma ASA (OB: VISTN) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $83.90M.
Over the last twelve months the share price has lost 20.6%, trading between 17.70 and 23.50.
Tweenvest scores Vistin Pharma ASA across four factors: quality 82/100, value 73/100, growth 63/100, dividend 80/100. Its strongest factor is quality.
VISTN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $83.90M
- Revenue (TTM)
- $43.61M
- P/E
- 11.43
- EPS
- 1.58
- Dividend yield
- 8.29%
- Beta (5Y)
- 0.58
- 52-week high
- Nkr23.50
- 52-week low
- Nkr17.70
- Avg volume (3M)
- —
- Shares outstanding
- 44.34M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| ECO Animal Health Group plcAIM: EAH | $85.63M | £0.96 | -2.55% |
| Chunghwa Chemical Synthesis & Biotech Co., Ltd.TWSE: 1762 | $85.04M | NT$35.35 | +4.74% |
| Protect Animal Health Inc.TPEX: 7850 | $84.75M | NT$27.75 | +13.96% |
| Anuh Pharma LimitedBSE: 506260 | $84.47M | Rs81.57 | -6.11% |
| ZIM Laboratories LimitedBSE: 541400 | $83.55M | Rs150.70 | +10.44% |
| Cognition Therapeutics, Inc.NasdaqCM: CGTX | $83.39M | $0.88 | -5.21% |
| Rafael Holdings, Inc.NYSE: RFL | $83.20M | $1.60 | +3.90% |
| HANDOK Inc.KOSE: A002390 | $83.10M | ₩8,600.00 | +0.47% |
Figures last refreshed Oct 11, 2026.